Drugs with this side effect as MedDRA Preferred Term
- Ge-132
- Movements involuntary: postmarketing
- L-Dmp
- LY146032
- Madopar
- Abnormal involuntary movements
- Stalevo 50
- Dyskinesia
- Movements involuntary
- Vallergan
- Zyprexa Relprevv
- acetaminophen
- alfentanil
- Dyskinesia
- Movement disorder: 7.9%
- alprazolam
- Dyskinesia: 1.7%
- Abnormal involuntary movements: 14.8%
- amantadine
- amiodarone
- Abnormal involuntary movements
- Movements involuntary
- amisulpride
- Dyskinesia: very common, 2% - 6%
- Movements involuntary: uncommon
- amitriptyline
- Abnormal involuntary movements
- amphetamine
- apomorphine
- aripiprazole
- Dyskinesia: 1%
- Movement disorder
- Buccoglossal syndrome
- Abnormal involuntary movements
- Movements involuntary
- asenapine
- Dyskinesia
- Movements involuntary
- baclofen
- bortezomib
- bromocriptine
- bupropion
- Dyskinesia: postmarketing, frequent
- buspirone
- Dyskinesia: postmarketing
- Movements involuntary: infrequent
- butorphanol
- Abnormal involuntary movements: infrequent
- cabergoline
- carbamazepine
- Dyskinesia
- Orofacial dyskinesia: rare
- Abnormal involuntary movements: postmarketing, uncommon
- carbidopa
- Dyskinesia: 12.2% - 16.5%
- Movements involuntary
- cefdinir
- Movements involuntary: postmarketing
- cetirizine
- Dyskinesia: postmarketing
- Orofacial dyskinesia: postmarketing
- Movement disorder: postmarketing
- cevimeline
- chlorambucil
- chloroquine
- chlorpheniramine
- chlorpromazine
- Orofacial dyskinesia
- Movements involuntary
- citalopram
- Dyskinesia: postmarketing
- Movement disorder
- clarithromycin
- clomipramine
- clozapine
- cyclizine
- deprenyl
- Dyskinesia: postmarketing, 2% - 6%
- Movements involuntary
- desloratadine
- Movement disorder: postmarketing
- dextrorphan
- diazepam
- dicyclomine
- Dyskinesia: postmarketing
- diethylpropion
- dothiepin
- doxapram
- doxazosin
- doxepin
- doxorubicin
- duloxetine
- Dyskinesia: postmarketing, infrequent, uncommon
- entacapone
- Dyskinesia: very common, 25% - 27%
- Movements involuntary
- ertapenem
- Dyskinesia: postmarketing
- estradiol
- felbamate
- flecainide
- Dyskinesia: postmarketing
- fluoxetine
- Dyskinesia: postmarketing, uncommon
- Movement disorder
- Buccoglossal syndrome: infrequent, uncommon
- fluphenazine
- fluphenazine decanoate
- Dyskinesia
- Movements involuntary
- fluvoxamine
- Dyskinesia: rare, infrequent
- fosphenytoin
- gabapentin
- Dyskinesia: postmarketing
- Movement disorder: postmarketing, rare
- Orofacial dyskinesia: rare
- granisetron
- haloperidol
- Dyskinesia
- Orofacial dyskinesia
- Movements involuntary
- hydromorphone
- Dyskinesia: postmarketing
- ifosfamide
- Movement disorder: postmarketing
- iloperidone
- indomethacin
- Muscle movement involuntary
- iopamidol
- lamotrigine
- Dyskinesia: infrequent
- Movement disorder: rare, infrequent
- levetiracetam
- Dyskinesia: postmarketing
- levodopa/carbidopa
- lisdexamfetamine dimesylate
- Dyskinesia: postmarketing
- loxapine
- Dyskinesia: uncommon
- Movements involuntary
- lurasidone
- Dyskinesia
- Abnormal involuntary movements
- maprotiline
- memantine
- Dyskinesia: postmarketing
- meperidine
- Muscle movement involuntary
- methylphenidate
- Dyskinesia: postmarketing, common
- metoclopramide
- Movements involuntary: postmarketing
- midazolam
- Movement disorder
- Movements involuntary
- mirtazapine
- Dyskinesia: infrequent
- Movement disorder: postmarketing
- mitotane
- modafinil
- Dyskinesia: postmarketing
- Orofacial dyskinesia
- molindone
- morphine
- olanzapine
- Dyskinesia
- Buccoglossal syndrome
- ondansetron
- Dyskinesia: uncommon
- Movement disorder: uncommon
- Orofacial dyskinesia: postmarketing
- paclitaxel
- paliperidone
- Dyskinesia: uncommon, 1% - 9%
- Movement disorder
- Abnormal involuntary movements
- palonosetron
- paroxetine
- Dyskinesia: rare, infrequent
- Movement disorder: postmarketing
- pergolide
- Dyskinesia: frequent, 62.4%
- perphenazine
- Dyskinesia
- Movements involuntary
- phenylpropanolamine
- phenytoin
- Dyskinesia: postmarketing
- pimozide
- Dyskinesia
- Movements involuntary
- pramipexole
- Dyskinesia: uncommon, very common, 17% - 47%
- pregabalin
- Dyskinesia: rare
- Movement disorder: infrequent
- prochlorperazine
- Dyskinesia
- Orofacial dyskinesia
- Movements involuntary
- promethazine
- propericiazine
- Dyskinesia
- Movements involuntary
- propofol
- quetiapine
- Dyskinesia: infrequent, 0% - 3%
- Movement disorder
- Buccoglossal syndrome: rare
- Movements involuntary: infrequent
- ranitidine
- rasagiline
- remifentanil
- Movements involuntary: 0% - 1.7%
- risperidone
- Dyskinesia: infrequent, 1% - 7%
- Movement disorder
- Abnormal involuntary movements
- rivastigmine
- Dyskinesia: common, frequent, 3%
- Movement disorder
- ropinirole
- Dyskinesia: infrequent, 2.4% - 34%
- ropivacaine
- rotigotine
- sertraline
- Dyskinesia: postmarketing, rare
- Movement disorder: postmarketing, common
- sumatriptan
- thalidomide
- thiothixene
- tiagabine
- Movement disorder: infrequent
- tizanidine
- tolcapone
- topiramate
- tramadol
- Movement disorder: postmarketing
- trazodone
- trifluoperazine
- Dyskinesia
- Orofacial dyskinesia
- Movements involuntary
- trimethoprim
- trovafloxacin
- venlafaxine
- Dyskinesia: very rare, postmarketing
- Buccoglossal syndrome: rare
- Movements involuntary: postmarketing
- vigabatrin
- Dyskinesia: postmarketing
- Movement disorder
- ziprasidone
- Dyskinesia: frequent, 1.2%
- Movement disorder
- Buccoglossal syndrome: frequent
- zonisamide
- Dyskinesia: rare
- Movement disorder: infrequent
- zuclopenthixol
- Dyskinesia
- Movements involuntary
|
Drugs with this indication
|